Table of Contents page: Journal of Pain and Symptom Management

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Full length article

Dose Conversion and Titration with a Novel, Once-Daily, OROS^® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

Mark Palangio,
Donald W Northfelt,
Russell K Portenoy,
...
Ralph T Doyle Jr.,
Bruce E Dornseif,
Michael C Damask

Published in issue: May 2002

p355-368

Putting Cancer Pain Management Regimens into Practice at Home

Karen L Schumacher,
Setsuko Koresawa,
Claudia West,
...
Debu Tripathy,
Peter Koo,
Christine Miaskowski

Published in issue: May 2002

p369-382

Controlling Cancer Pain in Primary Care

Stephen Barclay,
Chris Todd,
Gunn Grande,
Julian Lipscombe

Published in issue: May 2002

p383-392

Barriers to Effective Cancer Pain Management

Patsy M Yates,
Helen E Edwards,
Robyn E Nash,
...
Belinda J Fentiman,
Helen M Skerman,
Jake M Najman

Published in issue: May 2002

p393-405

Preliminary Evaluation of a Clinical Syndrome Approach to Assessing Cancer-Related Fatigue

Ian J Sadler,
Paul B Jacobsen,
Margaret Booth-Jones,
Heather Belanger,
Michael A Weitzner,
Karen K Fields

Published in issue: May 2002

p406-416

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer

Keiko Tanaka,
Tatsuo Akechi,
Toru Okuyama,
Yutaka Nishiwaki,
Yosuke Uchitomi

Published in issue: May 2002

p417-423

Assessing Differences in Care Needs and Service Utilization in Geriatric Palliative Care Patients

Martin M Evers,
Diane E Meier,
R.Sean Morrison

Published in issue: May 2002

p424-432

The Impact of Chronic Pain on Life in the Household

Marius A Kemler,
Carina A Furnée

Published in issue: May 2002

p433-441

Short communication

An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms

Dale E Theobald,
Kenneth L Kirsh,
Elizabeth Holtsclaw,
Kathleen Donaghy,
Steven D Passik

Published in issue: May 2002

p442-447

Latest

For Authors

Society

Journal Information

Access

Contact

Follow Us

May 2002

Full length article

Dose Conversion and Titration with a Novel, Once-Daily, OROS^® Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

Putting Cancer Pain Management Regimens into Practice at Home

Controlling Cancer Pain in Primary Care

The Prescribing Habits and Knowledge Base of General Practitioners

Barriers to Effective Cancer Pain Management

A Survey of Hospitalized Cancer Patients in Australia

Preliminary Evaluation of a Clinical Syndrome Approach to Assessing Cancer-Related Fatigue

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer

Assessing Differences in Care Needs and Service Utilization in Geriatric Palliative Care Patients

The Impact of Chronic Pain on Life in the Household

Short communication

An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms